The efficacy and safety of tranexamic acid in rheumatoid arthritis patients undergoing simultaneous bilateral total knee arthroplasty: a multicenter retrospective study
Open Access
- 15 May 2023
- journal article
- research article
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 24 (1) , 1-6
Abstract
Background: The efficacy and safety of tranexamic acid (TXA) in reducing blood loss following total knee arthroplasty (TKA) in patients with osteoarthritis have been widely confirmed. However, there is still a paucity of the evidences regarding the effectiveness of TXA in patients with rheumatoid arthritis (RA). The purpose of the study is to explore the efficacy and safety of intravenous TXA on blood loss and transfusion risk following simultaneous bilateral TKA (SBTKA) in patients with RA. Methods: As a multicenter retrospective study, a total of 74 patients diagnosed with RA who underwent SBTKA were assigned into TXA group (15 mg/kg intravenous TXA before skin incision, n = 50) and control group (no TXA use, n = 24). The primary outcomes were total blood loss (TBL) and intraoperative blood loss (IBL). The secondary outcomes were hemoglobin (Hb) and hematocrit (Hct) drop on postoperative day 3, transfusion rate and volume, ambulation time, length of stay, hospitalization expenses and the incidence of complications. Results: The mean TBL, IBL and transfusion volume in TXA group were significantly lower than those in control group. The Hb and Hct drop on postoperative day 3 in control group were higher than those in TXA group (p0.05). Conclusions: TXA could effectively reduce blood loss, decrease transfusion risk, shorten ambulation time and length of stay following SBTKA in patients with RA, without increasing the risk of complications.Keywords
Funding Information
- National Natural Science Foundation of China (82104896)
- National Health and Family Planning Commission of the People’s Republic of China (CN) program (201302007)
This publication has 42 references indexed in Scilit:
- Single dose intravenous tranexamic acid as effective as continuous infusion in primary total knee arthroplasty: a randomised clinical trialArchives of orthopaedic and trauma surgery, 2015
- Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic systemAnnals of the Rheumatic Diseases, 2014
- Oral versus intravenous tranexamic acid in enhanced-recovery primary total hip and knee replacementThe Bone & Joint Journal, 2013
- A Cost-Utility Analysis Comparing the Cost-Effectiveness of Simultaneous and Staged Bilateral Total Knee ArthroplastyJournal of Bone and Joint Surgery, 2013
- Rheumatoid Arthritis vs Osteoarthritis in Patients Receiving Total Knee Arthroplasty: Perioperative OutcomesThe Journal of Arthroplasty, 2013
- Hidden Blood Loss After Total Hip ArthroplastyThe Journal of Arthroplasty, 2011
- Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteriaAnnals of the Rheumatic Diseases, 2011
- TRANSFUSION COMPLICATIONS: Bacterial culture reduces but does not eliminate the risk of septic transfusion reactions to single‐donor plateletsTransfusion, 2009
- Perioperative hypercoagulability in patients with rheumatoid arthritis: Sonoclot studyJournal of Anesthesia, 2004
- Arthritis is linked to local and systemic activation of coagulation and fibrinolysis pathwaysJournal of Thrombosis and Haemostasis, 2003